Julia B. DeLuca

Julia B. DeLuca

Auto-generated profile, based on publicly available information

Julia B. DeLuca

Emiko Kamitani is a Senior Service Fellow, Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in American Journal of Public Health
Verified
Journal Article
Closed access
CLCynthia M. Lyles
Cynthia M. Lyles
LKLinda S. Kay
Linda S. Kay
NCNicole Crepaz
Nicole Crepaz
JHJeffrey H. Herbst
Jeffrey H. Herbst
WPWarren F. Passin
Warren F. Passin
MMMary M. Mullins
Mary M. Mullins
Objectives. The Centers for Disease Control and Prevention’s HIV/AIDS Prevention Research Synthesis Team conducted a systematic review of US-based HIV behavioral intervention research literature from 2000 through 2004 to identify interventions demonstrating best evidence of efficacy for reducing HIV risk. Methods. Standard systematic review methods were used. Each eligible study was reviewed on the basis of Prevention Research Synthesis Team efficacy criteria that focused on 3 domains: study design, implementation and analysis, and strength of evidence. Results. Eighteen interventions met the criteria for best evidence. Four targeted HIV-positive individuals. Of those targeting populations at risk for HIV, 4 targeted drug users, 6 targeted adults at risk because of heterosexual behaviors only, 2 targeted men who have sex with men, and 2 targeted youths at high risk. Eight interventions focused on women, and 13 had study samples with more than 50% minority participants. Significant intervention effects included increased condom use and reductions in unprotected sexual intercourse, number of sexual partners, injection drug use or needle sharing, and newly acquired sexually transmitted infections. Conclusions. Most of the best-evidence interventions are directly applicable for populations in greatest need of effective prevention programs; however, important gaps still exist.

1 June 2005
Verified
Journal Article
Closed access
JHJeffrey H Herbst
Jeffrey H Herbst
RSR Thomas Sherba
R Thomas Sherba
NCNicole Crepaz
Nicole Crepaz
JDJulia B Deluca
Julia B Deluca
LZLev Zohrabyan
Lev Zohrabyan
HTHIV/AIDS Prevention Research Synthesis Team
HIV/AIDS Prevention Research Synthesis Team

6 September 2019 in Journal of Women's Health
Verified
Journal Article
Closed access
EBErin Bradley
Erin Bradley
KFKaitlin Forsberg
Kaitlin Forsberg
JBJoshua E. Betts
Joshua E. Betts
JDJulia B. DeLuca
Julia B. DeLuca
EKEmiko Kamitani
Emiko Kamitani
KHKaren W. Hoover
Karen W. Hoover
Oral HIV pre-exposure prophylaxis (PrEP) is a highly effective pill that HIV-negative individuals can take once daily to prevent HIV infection. Although PrEP is a private, user-controlled method that empowers women to protect themselves without relying on a partner's behavior, women's PrEP use has been extremely low. We systematically reviewed the literature to identify and summarize factors that may be affecting PrEP implementation for women in the United States. We conducted a search of the Centers for Disease Control and Prevention HIV/AIDS Prevention Research Synthesis Project database (MEDLINE, EMBASE, and CINAHL) and PubMed to identify peer-reviewed studies published between January 2000 and April 2018 that reported U.S. women's or health care providers' PrEP knowledge or awareness, willingness to use or prescribe, attitudes, barriers and facilitators to use or prescription, or PrEP adherence and discontinuation influences. Thirty-nine studies (26 women, 13 providers) met the eligibility criteria. In these studies, 0%–33% of women had heard of PrEP. Between 51% and 97% of women were willing to try PrEP, and 60%–92% of providers were willing to prescribe PrEP to women. Implementation barriers included access, cost, stigma, and medical distrust. Three studies addressed adherence or discontinuation. PrEP knowledge is low among women and providers. However, women and providers generally have positive views when aware of PrEP, including a willingness to use or prescribe PrEP to women. Most of the implementation barriers highlighted in studies were social or structural factors ( e.g ., access). Additional studies are needed to address research gaps, including studies of PrEP adherence and discontinuation.

1 June 2007 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
NCNicole Crepaz
Nicole Crepaz
AHAngela K Horn
Angela K Horn
SRSima M Rama
Sima M Rama
TGTanesha Griffin
Tanesha Griffin
JDJulia B Deluca
Julia B Deluca
HTHIV/AIDS Prevention Research Synthesis Team
HIV/AIDS Prevention Research Synthesis Team
Interventions targeting sexually transmitted disease (STD) clinic patients provide an important opportunity to modify high-risk sex behaviors related to HIV/STD transmission. Identifying efficacious interventions for blacks and Hispanics is urgently needed because these 2 groups are disproportionately affected by the HIV/STD epidemics. This meta-analysis evaluates the efficacy of behavioral interventions in reducing unprotected sex and incident STD among black and Hispanic STD clinic patients. Comprehensive searches, including electronic databases (1988-2004), hand searches of journals (January 2004 to June 2005), reference lists of articles, and contacts with researchers, identified 18 randomized, controlled trials meeting the selection criteria. Interventions significantly reduced unprotected sex (odds ratio [OR] = 0.77; 95% confidence interval [CI] = 0.68-0.87; 14 trials; N = 11,590) and incident STD (OR = 0.85; 95% CI = 0.73-0.998; 13 trials; N = 16,172). Behavioral interventions provide an efficacious means of HIV/STD prevention for blacks and Hispanics who attend STD clinics.

3 March 2013 in AIDS and Behavior
Verified
Journal Article
Closed access
PDF file
ALAdrian Liau
Adrian Liau
HTHIV/AIDS Prevention Research Synthesis (PRS) Team
HIV/AIDS Prevention Research Synthesis (PRS) Team
NCNicole Crepaz
Nicole Crepaz
CLCynthia M. Lyles
Cynthia M. Lyles
DHDarrel H. Higa
Darrel H. Higa
GMGary Marks
Gary Marks

13 November 2018 in AIDS
Verified
Journal Article
Closed access
YMYuko Mizuno
Yuko Mizuno
DHDarrel H. Higa
Darrel H. Higa
CLCarolyn A. Leighton
Carolyn A. Leighton
KRKatherine B. Roland
Katherine B. Roland
JDJulia B. Deluca
Julia B. Deluca
LKLinda J. Koenig
Linda J. Koenig
To provide the first systematic review on the associations between HIV patient navigation and HIV care continuum outcomes (i.e., linkage to care, retention in care, ART uptake, medication adherence, and viral suppression) in the United States (U.S.). We identified primary research studies that addressed these associations and qualitatively assessed whether provision of patient navigation was positively associated with these outcomes, including strength of the evidence. A systematic review, including both electronic (MEDLINE [OVID], EMBASE [OVID], PsycINFO [OVID], and CINAHL [EBSCOhost]) online databases and manual searches, was conducted to locate studies published from January 1, 1996 through April 23, 2018. Twenty studies met our inclusion criteria. Of these, 17 found positive associations. Patient navigation was more likely to be positively associated with linkage to care (5 of 6 studies that assessed this association), retention in care (10 of 11), and viral suppression (11 of 15) than with antiretroviral (ART) uptake (1 of 4) or ART adherence (2 of 4). However, almost two-thirds of the 17 studies were of weak study quality, and only three used a randomized controlled trial (RCT) design. Available evidence suggests that patient navigation is a potentially effective strategy to enhance engagement in care among persons with HIV (PWH). However encouraging, the evidence is still weak. Studies with more rigorous methodological designs, and research examining characteristics of navigators or navigational programs associated with better outcomes, are warranted given the current interest and use of this strategy.